Buy & Sell Nasdaq Inc (NDAQ) – Nasdaq Inc Price Today
Aura AI Summary
Key Stats
- $50.61BMarket Cap
- FinancialsSector
- -8.54%3M Drawdown
- $57.68BEnterprise Value
- 1.25%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 116 daysTypical Hold Time
Nasdaq Inc (NDAQ) is currently valued at a market capitalization of $50.61B, with an enterprise value of $57.68B. Over the past 52 weeks, Nasdaq Inc has traded between a low of $79.01 and a high of $100.98, highlighting its annual price range. Over the past three months, Nasdaq Inc has recorded a drawdown of -8.54%, reflecting recent price volatility. Nasdaq Inc offers a dividend yield of 1.25%, with the most recent dividend of $0.27 paid on 16 Mar 26. On average, investors hold Nasdaq Inc for approximately 116 days, indicating typical investor behavior on the platform.
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Most Recent News
Semiconductor recovery driven by supply constraints and pricing, not unit growth, led by memory chips for AI.
The semiconductor industry recovery is now led by memory chip pricing increases due to supply constraints rather than unit shipment growth. After a severe downturn in 2022, memory manufacturers cut capital expenditures and limited capacity expansion,...
Megan Holdings receives Nasdaq notice for falling below $1 minimum bid price, must regain compliance by Nov 2026.
Megan Holdings Limited announced it received a Nasdaq notification for not meeting the minimum bid price of $1 per share, with its shares trading below this threshold for 30 consecutive business days. The company has 180 days, until November 9, 2026,...
Absci insider buys shares amid financial challenges and positive clinical trial progress
A director at Absci purchased 37,453 shares, showing confidence despite the company's Q1 2026 revenue missing estimates by 90%. Absci reported a smaller-than-expected loss and progress in its ABS-201 clinical trial with positive safety data. The insi...